EUVIMEDEUVIMED entdecken
Crossref

A 2023 Agenda for Substance Use Prevention and Treatment in the US

Rahul Gupta, Nicholas F Wright, David R Holtgrave

JAMA · 2023

DOI: 10.1001/jama.2023.1090 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JAMA, 2023. Verfasst von Rahul Gupta und 2 weiteren Autor:innen. Beteiligte Einrichtung: White House Office of National Drug Control Policy, Washington, DC. Hauptthemen laut MEDLINE: Substance-Related Disorders, Health Policy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 8 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In this Viewpoint, officials from the White House Office of National Drug Control Policy describe 3 actions that health care personnel can take to expand prevention and treatment of substance misuse and overdose.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Substance-Related DisordersHealth PolicyHumansAnalgesics, OpioidDrug OverdoseOpioid-Related DisordersUnited States

Substanzen

Analgesics, Opioid

Autor:innen und Institutionen

  • White House Office of National Drug Control Policy, Washington, DC.

Zitieren

APA

Gupta, R., Wright, N. F., & Holtgrave, D. R. (2023). A 2023 Agenda for Substance Use Prevention and Treatment in the US. JAMA. https://doi.org/10.1001/jama.2023.1090

Vancouver

Gupta R, Wright NF, Holtgrave DR. A 2023 Agenda for Substance Use Prevention and Treatment in the US. JAMA. 2023. doi:10.1001/jama.2023.1090

BibTeX
@article{Gupta2023,
  author = {Gupta, Rahul and Wright, Nicholas F and Holtgrave, David R},
  title = {A 2023 Agenda for Substance Use Prevention and Treatment in the US},
  journal = {JAMA},
  year = {2023},
  doi = {10.1001/jama.2023.1090}
}
Kostenlos starten →